Mwyngil Therapeutics Partners with Expert Systems to Enhance GPR75 Research for Chronic Diseases Mwyngil Therapeutics has signed a significant licensing agreement with Expert Systems Inc. to enhance therapies for chronic diseases like obesity and diabetes.

Mwyngil Therapeutics Partners with Expert Systems to Enhance GPR75 Research for Chronic Diseases #United_States #Dover #Expert_Systems #Mwyngil_Therapeutics #GPR75_Modulators

Mondego Bio: A New Frontier in Immuno-Oncology Funding Success Mondego Bio has emerged from Expert Systems Inc. with Series A funding aimed at combating immune resistance in solid tumors, revolutionizing cancer treatments.

Mondego Bio: A New Frontier in Immuno-Oncology Funding Success #Portugal #Expert_Systems #Mondego_Bio #PTPN2_inhibitors #Cantanhede

Mair Therapeutics Launches with Pre-Seed Funding to Combat Parkinson's Disease Mair Therapeutics has secured pre-seed funding and aims to develop innovative therapies targeting Parkinson's Disease, addressing unmet medical needs.

Mair Therapeutics Launches with Pre-Seed Funding to Combat Parkinson's Disease #Netherlands #Parkinson's_Disease #Expert_Systems #Nijmegen #Mair_Therapeutics

Expert Systems Achieves Major Progress with Lonitoclax for Cancer Treatment Development Expert Systems has marked a significant milestone in the clinical development of Lonitoclax, a leading BCL-2 inhibitor promising safer oncology treatments.

Expert Systems Achieves Major Progress with Lonitoclax for Cancer Treatment Development #USA #Rockville #Lomond_Therapeutics #Lonitoclax #Expert_Systems